Cargando…
Targeting Lung Cancer Stem Cells: Research and Clinical Impacts
Lung cancer is the most common cancer worldwide, accounting for 1.8 million new cases and 1.6 million deaths in 2012. Non-small cell lung cancer (NSCLC), which is one of two types of lung cancer, accounts for 85–90% of all lung cancers. Despite advances in therapy, lung cancer still remains a leadin...
Autores principales: | Zakaria, Norashikin, Satar, Nazilah Abdul, Abu Halim, Noor Hanis, Ngalim, Siti Hawa, Yusoff, Narazah Mohd, Lin, Juntang, Yahaya, Badrul Hisham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418222/ https://www.ncbi.nlm.nih.gov/pubmed/28529925 http://dx.doi.org/10.3389/fonc.2017.00080 |
Ejemplares similares
-
Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells
por: Zakaria, Norashikin, et al.
Publicado: (2018) -
Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines
por: BAHARUDDIN, PUTERI, et al.
Publicado: (2016) -
The Effects of Lentivirus-Mediated Gene Silencing of RARβ on the Stemness Capability of Non-Small Cell Lung Cancer
por: Abu Halim, Noor Hanis, et al.
Publicado: (2021) -
Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines
por: Abdul Satar, Nazilah, et al.
Publicado: (2021) -
Conditioned Medium of Human Menstrual Blood-Derived Endometrial Stem Cells Protects Against MPP(+)-Induced Cytotoxicity in vitro
por: Li, Han, et al.
Publicado: (2019)